Carreras MC, Poderoso JJ. Mitochondrial nitric oxide in the signaling of cell-integrated responses. Am J Physiol Cell Physiol 292: C1569 -C1580, 2007; doi:10.1152/ajpcell.00248.2006.-Mitochondria are the specialized organelles for energy metabolism, but, as a typical example of system biology, they also activate a multiplicity of pathways that modulate cell proliferation and mitochondrial biogenesis or oppositely promote cell arrest and programmed cell death by a limited number of oxidative or nitrosative reactions. These reactions are influenced by matrix nitric oxide (NO) steady-state concentration, either from local production or by gas diffusion to mitochondria from the canonical sources. Likewise, in a range of ϳ30 -200 nM, NO turns mitochondrial O 2 utilization down by binding to cytochrome oxidase and elicits a burst of superoxide anion and hydrogen peroxide that diffuses outside mitochondria. Depending on NO levels and antioxidant defenses, more or less H 2O2 accumulates in cytosol and nucleus, and the resulting redox grading contributes to dual activation of proliferating and proapoptotic cascades, like ERK1/2 or p38 MAPK. Moreover, these sequential activating pathways participate in rat liver and brain development and in thyroid modulation of mitochondrial metabolism and contribute to hypothyroid phenotype through complex I nitration. On the contrary, lack of NO disrupts pathways like S-nitrosylation or H 2O2 production and likewise is a gateway to disease in amyotrophic lateral sclerosis with superoxide dismutase 1 mutations or to cancer proliferation.
MITOCHONDRIA PLAY A PIVOTAL role in cell physiology, producing the cellular energy and acting as signaling organelles. A mitochondria-based network elicits a multiplicity of effects and responses, depending on the course of cell life and on the environmental stimuli. This organization resulted from the selective pressure applied on eukaryotes to evolve the original endosymbiont process between bacteria, i.e., Cyanobacteria sp., and the primordial prokaryote structure. Accordingly, contribution of mitochondria includes several cohorts of integrated biochemical pathways shared with nucleus and mainly directed to execute the different cell programs or with the plasma membrane to elicit the responses to environmental challenges. Interestingly, mitochondrial pathways involve a limited number of reactions; depending on the steady-state concentrations of substrates and products and on the rate of oxidative reactions, there exist dual or even opposite effects on cell responses.
NITRIC OXIDE IN MITOCHONDRIA
Mitochondria are the central organelles in cell bioenergetics. Most available oxygen is consumed in the electron transfer chain, placed in the inner membrane of the two membranes that limit the differentiated mitochondrial compartment. Electron transfer through mitochondrial complexes I, III, and IV is joined to proton pumping across the inner membrane, creating a proton electrochemical gradient between the intermembrane space and the matrix. The gradient is dissipated by the reentry of protons through F 1 F 0 ATP synthase channels (complex V), which couple ATP synthesis to the electron transfer activity. From a classic perspective, it is accepted that the rate of this process is regulated by O 2 and substrate availabilities as well as by the ADP-to-ATP ratio, likely the main mitochondrial modulator in response to cell demands.
During the past years, significant regulatory effects of nitric oxide (NO) on mitochondrial respiration became evident as resulting from its high-affinity binding to cytochrome oxidase (COX), the final electron acceptor (19) . The synthesis of NO from L-arginine and O 2 is catalyzed by nitric oxide synthases (NOS) (92) . There exist three canonical isoforms [neuronal (NOS I or nNOS), inducible (NOS II), and endothelial (NOS III)] and a significant number of spliced and posttranslationally modified variants. In addition, new isoforms or mitochondrial variants of NOS (mtNOS) were recently described in rat liver (60, 63) , thymus (29) , and brain (119) ; mtNOS is bound to mitochondrial PDZ domains of COX (57, 103) and to complex I (57), thus favoring a steric relationship between the released NO, vectorially directed to the matrix and inner membrane, and the control of respiration. In pathological conditions such as extreme hypoxia, mitochondrial NO could come either from stimulated NOS (116, 142) or from the reduction of nitrite by COX (39) .
NOS I and III (45, 82) are constitutively expressed in different tissues, although their expression is tightly regulated. These enzymes are bound to anchoring proteins in cell membrane (caveolin) and in synaptic vesicles (PSD95) in skeletal and cardiac muscles (dystrophin) and to heat shock protein (HSP) 90 or 70 chaperones (79) . The interaction with these proteins may involve different effects: 1) increased (HSP90-NOS) or decreased (caveolin-NOS) enzyme activity, 2) modified subcellular traffic (dystrophin impedes NOS I traffic to mitochondria) (76) , and 3) participation in ubiquitination and degradation (54) . Constitutive NOS are activated by Ca 2ϩ pulses after activation of cell surface receptors by effectors like bradykinin or acetylcholine (endothelial NOS III) or excitatory amino acids like glutamate (neuronal synaptic NOS I) (45) . NOS I and III are characterized by fast and transient responses to facilitate neural transmission or to induce a prompt vasodilation in response to changes in blood flow. In contrast, NOS II is not constitutive and does not depend on Ca 2ϩ concentration; NOS II gene expression is modulated by inflammatory mediators, like cytokines TNF-␣, IFN-␥, and LPS that activate transcription factors like NF-B or AP-1 (59) . The mtNOS is nNOS-␣ translocated to mitochondria with specific posttranslational modifications such as myristoylation and phosphorylation of Ser-1412 in an Akt-dependent motif (RXRXXS/T); it is constitutively expressed and Ca 2ϩ dependent, and it is subjected to modulation by drugs or hormones or during development (21, 32, 34, 119) .
The activities of classic NOS isoforms are able to sustain NO cytosolic concentrations large enough to reach mitochondria. The diffusion coefficient of NO in aqueous solutions is similar to that of O 2 , in ϳ4 ϫ 10 Ϫ6 cm 2 /s (143); activation of endothelium is compatible with a concentration in the arterial wall of 2 M NO. Most NO binds to cytosolic compounds, like myoglobin (35, 111) . Therefore, mitochondrial NO coming from classic cytosolic NOS results in a considerably lower concentration, ϳ20 -100 nM (18, 111) ; however, it may increase by fivefold after induction of inducible NOS in endotoxemia (14) . In this condition, both increased NO and NOderived superoxide anion (O 2 Ϫ ) favor the formation of intramitochondrial peroxynitrite (13) .
In addition, new evidence supports the notion that mitochondrial NO steady-state concentration is also sustained by the constitutive activity of mtNOS (64) . It is noteworthy that changes in the expression and activities of NOS isoforms, particularly of intra-mtNOS, will be followed by significant variations in NO steady-state levels in the relatively small and well-differentiated mitochondrial compartment.
OXYGEN AND NO UTILIZATION
In mitochondria, NO acts at different levels. As previously reported by us and others, in rat heart mitochondria (108), skeletal muscle, and liver mitochondria (48, 110) and synaptosomes (25) , NO reversibly binds to Cu 2ϩ B center of COX and consequently inhibits electron transfer to O 2 and mitochondrial O 2 uptake. The same effects were described by our group in the isolated rat heart (111) and by others in different organs (78) and in the whole animal, evaluated as systemic oxygen uptake (130) . It is noteworthy that NO-dependent inhibition of O 2 utilization is achieved at very low physiological NO concentrations; 50 -100 nM NO inhibits by half the activity of COX (108, 110) .
An elegant computational study on mitochondrial NO effects was done by Antunes et al. (5 (20 -65) . In addition, the model predicted that, at the micromolar levels of oxygen found in tissues, the rate of respiration would be nearly saturated with O 2 (Eq. 1) (for details, see supporting text in
where brackets indicate concentration, k O2app is apparent rate of O 2 uptake, tot is total, and k IV is the rate of O 2 consumption in state 4. With respect to NO inhibitory effects, the main results obtained by the authors reflected that, at the same NO concentration, the degree of inhibition increased when the oxygen concentration decreased and that the degree of inhibition caused by the same concentrations of NO and O 2 was much more pronounced in state 3 than in state 4 (5) . NO inhibited mitochondrial respiration at high ratios (Ͼ1,000) of O 2 to NO, and the onset of inhibition was extremely fast, occurring virtually immediately after NO addition. Therefore, mathematical calculation results were identical to those observed experimentally (16, 20, 24, 97, 137) .
To evaluate whether the fast inhibition of mitochondrial respiration by NO represents a simple competition between NO and O 2 for COX, the formation of the complex between COX and NO was followed by the authors after addition of NO. As observed experimentally (62, 139) , the formation of COX-NO occurred within a few seconds after NO addition. The time scale for the inhibition of COX by NO is given by k NOon ϫ [NO]; at typical [NO] ϭ 10 Ϫ8 M, a time scale of ϳ1 s was obtained, with higher NO concentrations (10 Ϫ7 to 10 Ϫ6 M) giving faster inhibitions (110) . Therefore, the fast inhibition of COX by NO is completely compatible with a direct competition between NO and O 2 for COX; at the steady state and in the presence of NO, the rate of respiration is given by Eq. 2, which describes a simple linear competitive inhibition of COX by NO with an inhibition constant (K i ) given by k NOoff /k NOon (k NOon and k NOoff are defined in supporting material of Ref. 5). Thus NO acts by increasing the apparent K 0.5 , as observed experimentally (16, 20) .
As stated by Antunes et al. (5) , the ratio of the respiration rate in the absence of NO to the respiration rate in the presence of NO, deduced by combining Eqs. 1 and 2, is Noninhibited respiratory rate [NO] Ϫ inhibited respiratory rate
and the concentration of NO that inhibits mitochondrial respiration by 50% (IC 50 ) is given by Eq. 4:
These calculations are useful for isolated COX, although they should be modified to include additional NO effects on other respiratory components, as occurs in vivo. Accordingly, NO inhibits COX and increases the reduction levels of the components of the electron transfer chain, including ubiquinol and ubisemiquinone, on the substrate side of COX and reacts directly with ubiquinol to produce nitroxyl anion (NO Ϫ ) and ubisemiquinone (109, 110) . A decade ago, we found that mitochondrial utilization of NO involves a similar inhibition of the b-c1 region at complex III that increases the production rate of O 2 Ϫ and H 2 O 2 (108, 109) . Hence, the reactions of NO with components or products of the mitochondrial respiratory chain are, as in bacteria, reductive and yield NO Ϫ or they are oxidative and yield ONOO Ϫ (18) .
NO UTILIZATION IS OBLIGATORILY LINKED TO THE MITOCHONDRIAL PRODUCTION OF OXYGEN ACTIVE SPECIES
Almost 20 yr ago, Boveris et al. (22) reported that mitochondria produce oxygen active species by auto-oxidation of intermediary ubisemiquinone (UQ), a transitional redox state of membrane ubiquinol. About 2-3% of utilized O 2 undergoes one-electron reduction by ubisemiquinone forming O 2 Ϫ . In the presence of mitochondrial manganese superoxide dismutase (MnSOD), most of O 2 Ϫ is dismutated to H 2 O 2 , which is freely diffusible to cytosol.
To sustain this notion, the ubisemiquinone pool and O 2 Ϫ production rate can be experimentally increased by the utilization of specific compounds like antimycin (complex III inhibitor), which blocks electron flow between cytochromes b and c (22) .
Considering that mitochondrial NO metabolism involves regulatory aspects on O 2 consumption and O 2 Ϫ and H 2 O 2 production and the resultant effects of freely diffusible H 2 O 2 outside mitochondria on gene expression and cell signaling, it is surmised that these activities markedly contribute to the mitochondrial modulation of life processes.
It is remarkable that the enzymes of the electron transfer chain show a different sensitivity to NO (108) . Accordingly, at 0.3-0.5 M, NO inhibits electron transfer between cytochromes b and c1 in the respiratory chain (108, 111) , whereas relatively prolonged 0.5-1 M NO exposure selectively inhibits the NADH dehydrogenase activity at mitochondrial complex I in intact cells (50) and isolated mitochondria (120), a hallmark of neurodegenerative experimental or clinical entities like Parkinson disease. Finally, albeit controversial, some authors believe NO is able to inhibit complex II activity, which probably depends on the time of exposure and the type of utilized mitochondria in the experimental setting (38, 133) . As a consequence of the above-mentioned NO effects, it results in an increase in the reduction level of the mitochondrial components, which, in turn, favors the reaction of NO with ubiquinol and with complex I components. NO oxidizes ubiquinol with a second-order reaction rate constant of 2.3 ϫ 10 3 M Ϫ1 ⅐s Ϫ1 (109, 110) to the respective semiquinone (reaction 3), which decays by auto-oxidation to ubiquinone, forming O 2 Ϫ (reaction 3 followed by reaction 2).
Finally, O 2 Ϫ reacts with NO to form peroxynitrite anion or dismutates to H 2 O 2 , a reaction catalized by MnSOD (reactions 4 and 5):
Considering the reaction rate constants of reactions 4 and 5 [2 ϫ 10 10 and 2.3 ϫ 10 9 M Ϫ1 ⅐s Ϫ1 , respectively (56 and 80)], its relative participation in mitochondrial metabolism will depend on NO concentration and on MnSOD level. In agreement, supplementation of submitochondrial particles with complex I or complex II substrates increases by 10-to 20-fold NO utilization; in contrast, addition of superoxide dismutase (SOD) decreases NO utilization and prolongs its mean life and increases H 2 O 2 (110) . From these observations, it is noteworthy that 1) in mitochondria, most NO decays by reaction 4 and 2) depending on NO and MnSOD concentrations, mitochondrial utilization of NO involves the formation of H 2 O 2 , a species freely diffusible outside of mitochondria (30) .
From this view, the modulation and activities of NO utilization pathways and mitochondrial NO, superoxide anion, H 2 O 2 , and peroxynitrite yield participate significantly in life processes. In the past decades, cumulative evidence has shown that H 2 O 2 and the related oxidative stress level play significant roles in the activation of signaling pathways to control cell proliferation, differentiation, apoptosis, and senescence. Furthermore, redox status is clearly related to the activity of growth factors and to cell transformation and cancer. Our underlying proposal is that grading expression and activities of NOS isoforms and the concentration of matrix NO modulate H 2 O 2 and oxidative stress. As described in cell transformation (71) , concomitant changes in MnSOD have two effects: to increase cytosolic H 2 O 2 and to prolong NO effects on mitochondria. These two effects are the principles of system biology that signal for different physiological or pathological responses.
PRODUCTION AND CELL STEADY STATE CONCENTRATION OF H2O2
The mitochondrial and cytosolic rates of formation and utilization of NO (17): (17) . It is noteworthy that after "in vitro" supplementation of exogenous H 2 O 2 to cell cultures, antioxidant enzymes will set the [H 2 O 2 ] ss to a considerably lower value in the intracellular milieu. In agreement and at a similar H 2 O 2 concentration (1 M), we observed an increase of the proliferation rate of PO7 lung tumor cells (58) . In the same way and considering oncogenic transformation as a state of uncontrolled proliferation with no differentiation, H 2 O 2 and oxidative stress have been accepted to have a major role (74, 135, 136) . In an elegant study, Arnold et al. (7) showed that transfection of oxidase Nox1 to NIH/3T3 fibroblasts, which increases cell H 2 O 2 levels by fivefold, resulted in a transformed phenotype with aggressive tumor formation. In this study, cells were reverted to a normal phenotype by cotransfection with catalase, and the authors concluded that a major role of H 2 O 2 is to activate genes related to the proliferating cascade.
On the other hand, high H 2 O 2 concentration (100 -200 M) induces temporary cell cycle arrest followed by overexpression of genes encoding antioxidant and protective enzymes in fibroblasts (113, 114) . Even at higher concentrations (250 -400 M), H 2 O 2 induces an almost permanent growth-arrested state but without cell damage.
Therefore, the progression of NO and H 2 O 2 effects from proliferation to cell cycle arrest and differentiation arises in differential effects elicited by low and high cellular concentrations to related effects, such as 1) kinase activation or inhibition (112), 2) effects on cyclins (37) (37) reported that oxidative and osmotic stresses decrease cyclin D 1 activity and expression, the former by activating p38 pathway (37) . This effect is due to phosphorylation of cyclin D 1 at Thr-286, which leads to the ubiquitination of the enzyme. The same effects were observed by Awad and Grappuso (8) who reported a temporal inverse correlation between activation of p38 MAPK and cyclin D 1 content during liver development or liver regeneration in the rat. Similarly, NO activates p38 MAPK and suppresses proliferation through the activation of JAK2-STAT5 and cyclin D 1 /cdk4 (70) . In accordance, the responses to shear stress of cultured microvascular endothelial cells are mediated by signal pathways involving both production of NO and activation of p38 MAPK pathway (93) .
Considering the occurrence of reactions 2-5 in mitochondria, previously, our group (32, 57) attempted to connect oxidative stress and NO levels to MAPKs, D cyclins, and cell proliferation. Our studies confirmed that NO yield and the oxidative stress level modulate the different cell responses.
Both H 2 O 2 and NO react with thiol groups of cysteine, methionine, or another amino acids that may modify the activity of tyrosine kinases, tyrosine phosphatases, and other proteins (10, 140) . Another mechanism is the activation of specific phosphorylation cascades that participate in the progression of the cell cycle; for instance, H 2 O 2 acts as a messenger in growth factor-induced p70(S6k) signaling pathway in mouse epidermal cells, which plays an important role in the transition from G 0 /G 1 to S phase of the cell cycle (9) . Finally, our group (2) observed ERK1/2 activation in brain mitochondria by very low concentrations of H 2 O 2 (0.1 M) but kinase inhibition when cells or isolated organelles were exposed to higher H 2 O 2 concentrations (1-10 M). It is not clear whether it implies a direct redox effect on the protein or actions on ERK-MEK (MAPK kinase) interactions. In this way, it was proposed that duration of MAPK activation determines whether a stimulus produces proliferation or differentiation (69) . Activation of a myeloid leukemia cell line (TF-1a) by granulocyte/macrophage colony-stimulating factor induced only a transient activation of MEK and ERK1/2 and 50% increase in cell proliferation, whereas prolonged stimulation with 10 Ϫ8 to 10 Ϫ6 M PMA underwent 91-98% cell differentiation without proliferation. The findings gain significance considering that ERK1/2 are activated by ROS (134) .
Antiproliferative effects are related to suppression of growth signals or potentiation of inhibitory signals and to resulting changes in cell cycle regulators such as p21, p27, cyclins, and retinoblastoma protein. The proapoptotic effects depend on translocation of Bax to mitochondria and generation of ROS and ultimately on the release of cytochrome c but in a caspaseindependent manner. For instance, activation of p38 MAPK and cell cycle arrest may finally progress to apoptosis in the presence of NO, which may activate the p38 MAPK pathway. In accord, the p38 inhibitor SB-203580 blocks proapoptotic effects of NO in SH-SY5Y neurons (94) . The activating NO effects and p38 MAPK signaling probably result in Bax translocation to mitochondria, a well-known constituent of programmed cell death (61). Kurata (81) reported that low oxidative stress (20 M H 2 O 2 ) causes a rapid activation of p38 MAPK cascade, with phosphorylation of MKK3/6 and p38 MAPK and activating transcription factors (ATF)-1 (cAMP response element-binding protein) and ATF-2. These effects were associated with mitotic arrest and inhibition of cell division in phase M of the cell cycle during 24 h and were cancelled by N-acetylcysteine or SB-203580, a specific p38 MAPK inhibitor. Similar effects were described by Sahl et al. (125) who observed that H 2 O 2 -induced cellular injury depends on JNK activation. In this case, also p38 and ERK were activated by H 2 O 2 ; however, only JNK-related injuring effects were inhibited by the MEK inhibitor PD-98059. Moreover, JNK phosphorylation of p53 is important for the stabilization of proapoptotic p53 protein (28) . Early activation of p38 MAPK and ERK does not seem to be dependent on cytotoxic factors like intracellular Ca 2ϩ movements. These results suggest that physiological H 2 O 2 -dependent activation of p38 MAPK may proceed many steps before a significant Ca 2ϩ release from intracellular and mitochondrial stores and that Ca 2ϩ -dependent tyrosine kinase-induced activation of SAPK/ JNK reflects the progression of cell injury (73) .
NITRATION AND NITROSYLATION OF MITOCHONDRIAL COMPONENTS: THE THYROID MODEL
Depending on the antioxidant levels, the consequence of high matrix [NO] ss is that nitrosative and nitrative (and oxidative) reactions are magnified in mitochondria. The main mitochondrial antioxidant defense is MnSOD. At the same SOD level, the production of ONOO Ϫ (and concurrent nitration) at 0.02 or 0.2 M NO will be completely different. Dismutation of O 2 Ϫ by SOD proceeds with an order of magnitude lower than formation of peroxynitrite (10 9 vs. 10 10 M Ϫ1 ⅐s Ϫ1 ) (80); thus it may hardly compete with ONOO Ϫ formation at high NO levels.
NO has both pro-and antiapoptotic effects. Some antiapoptotic effects include S-nitrosylation and inhibition of caspases, increase of HSPs and Bcl-2, and activation of Akt/PKB, which induces cytoprotective gene expression through NF-B activation (85) . S-nitrosylation is the modification of critical cysteine residues on proteins; dysregulation of this process by increased NO production has been linked to pathophysiology (86) . Accordingly, endogenous NO production inhibits apoptosis of pulmonary epithelial cells in culture (75) and the apoptosis induced by bleomycin (53, 124) ; inhaled NO protects against apoptosis after hyperoxia (68) or ischemia-reperfusion injury (145) . On the other hand, proapoptotic effects of NO include inhibition of NF-B, decreased Bcl-2 expression (87) (88) (89) 118) , and increased p53 expression, both by NO-mediated inhibition of proteasome degradation and by direct DNA damage.
Recent reported data suggest that excessive NO production and protein S-nitrosylation may contribute to disease. For instance, the E3 ligase parkin is aberrantly S-nitrosylated because of increased NO production in Parkinson disease (47, 146) . S-nitrosylation inhibits parkin activity, leading to the accumulation of misfolded proteins and to abnormal aggrega-tion as Lewy bodies, which contribute to apoptosis of dopaminergic neurons.
On the other hand, as referred in reaction 4, nitration on tyrosine, cysteine, or tryptophan follows the formation of peroxynitrite or protein exposure to NO 2 ⅐; ONOO Ϫ -dependent tyrosine nitration is a radical-radical reaction between tyrosyl and caged distributed NO 2 ⅐ and OH⅐ (129) .
In mitochondria, most of O 2 Ϫ formation occurs in complexes III and I; however, other mitochondrial enzymes, like monoamino oxidase, could contribute to ROS production (3) . Thus, at high NO, ONOO Ϫ formation is expected to specially proceed in those localizations. Clementi et al. (49) reported complex I inhibition in intact macrophages exposed to an NO donor, and we subsequently confirmed complex I inhibition and protein nitration in intact brain and liver mitochondria exposed to NO in a prolonged fashion. The inhibition of complex I limits the flow of electrons from NADH to the ubiquinol pool and markedly increases the O 2 Ϫ yield (36). However, it has been reported that, in intact mitochondria, rotenone inhibition of complex I did not increase ROS production with complex I substrates in myocardial ischemia (43) . Similar to the NADH dehydrogenase site of electron leak forming complex I being directed into the matrix side of the inner mitochondrial membrane, in mitochondria, O 2 Ϫ can be detoxified by matrix antioxidant defense systems. Therefore, ROS production may differ substantially in mitochondria and corresponding submitochondrial particles that do not contain antioxidant enzymes.
To clearly exemplify mitochondrial effects of NO and the subsequent cohort of effects, we studied the hypothyroid condition. Thyroid status is crucial for energy homeostasis, and its physiological roles in growth and in organ and cell differentiation have been extensively studied. Thyroid hormone effects are exerted on mitochondria of specific target tissues like liver and skeletal muscle, whereas oxidative metabolism of other organs like brain is not affected (117) . The action of thyroid hormone on respiratory functions has been considered to be operating at two levels: by altering mitochondrial inner membrane composition and permeability and by influencing respiratory gene expression. Thyroid status affects simultaneously the mitochondrial cytochrome content; in particular, cytochrome aa 3 is strongly affected because it decreases by 80% in hypothyroidism, whereas it increases by 130% in hyperthyroidism (99) . Changes in properties and composition of mitochondrial membranes, particularly in cardiolipin content, lead to variations of redox enzyme activities (72, 126) and in proton leak (23) . However, although direct or transcriptional effects have considerable impact on oxidative metabolism, it is not defined how thyroid hormones set body metabolic rate. Considering NO effects on O 2 uptake, we analyzed the effects of thyroid status on mtNOS content (34, 57) . At low levels of 3,3Ј,5-triiodothyronine (T 3 ) in hypothyroidism, nNOS mRNA increased by threefold and nNOS translocation to mitochondria was favored with concomitant increase of mtNOS expression and activity. Two effects emerged from nNOS confinement. First, decreased O 2 consumption was more sensitive to Larginine and to the NOS inhibitor N G -monomethyl-L-arginine, indicating the modulation of O 2 uptake by mtNOS. Second, high matrix NO resulted in high O 2 Ϫ and H 2 O 2 yields and to formation of peroxynitrite. Mitochondrial redox contribution to the activation of MAPK cascades was also confirmed in the hypothyroid model. Low T 3 -dependent mtNOS activation resulted in high oxidant production (H 2 O 2 and peroxynitrite), with the concomitant activation of p38 MAPK and the inactivation of ERK1/2. As shown before, this MAPK pattern is consistent with cell cycle arrest and inhibition of cell proliferation, a hallmark of hypothyroidism. A similar effect of a NOS inhibitor [N -nitro-L-arginine methyl ester (L-NAME)] or T 3 replacement in tuning hypothyroid cell signaling back to control status indicates that differential MAPK activation and cyclin D 1 expression should not depend on thyroid hormone themselves but on the relative production of mitochondrial oxidants, NO and peroxynitrite, at the different T 3 levels.
In addition, an extensive nitration of mitochondrial complex I proteins in this model (36, 57) was associated with a markedly reduced rate of electron transfer to ubiquinol acceptor, contributing to perpetuation of the process (Fig. 1) (57) . Complex I derangement and decreased basal metabolic rate were reverted by previous administration of L-NAME to the hypothyroid rats. These findings suggest that most of O 2 consumption inhibition in hypothyroidism is the consequence of complex I inhibition by NO-ONOO Ϫ overproduced by increased Fig. 1 . Transcriptional increase of neuronal nitric oxide synthase (nNOS) determines extensive binding to complex I and IV and contributes to hypothyroid phenotype. At low 3,3Ј,5-triiodothyronine (T3) levels, there is increased nNOS transcription, translation, and translocation into mitochondria, resulting in high mitochondrial NOS (mtNOS) activity and increased nitric oxide (NO), ONOO Ϫ , and H2O2 levels, nitration of mitochondrial proteins, and inhibition of complex I and IV. Top left: nitration of components of mitochondrial complex I from control, hyper-, and hypothyroid rat livers. MW, molecular weight; MnSOD, manganese superoxide dismutase; 2D, two dimensional. translocated nNOS (mtNOS). It is interesting that lack of T 3 stimulates nNOS gene expression, suggesting the existence of a tonic gene inhibition relying on effects of T 3 receptor dimers on the transcriptional machinery.
MITOCHONDRIA, CELL PROGRAMMED PROLIFERATION, AND NORMAL DEVELOPMENT
Cell proliferation is a complex programmed process responding to internal and periodical stimuli, to environmental ones, or both. Typically, growth factors elicit a cascade of events, including activation of kinases and transcription factors, that ultimately act on gene modulation by interacting with promoters or by increasing expression or activities of co-or transactivators and co-or transrepressors. To stimulate cell cycle transition from G 0 resting state to G 1 check point, cyclins are phosphorylated by cdk kinases (105, 131) . Cyclin D 1 is implicated in the control of G 1 phase progression in hepatocytes and other proliferating cell types, and its expression is positively regulated by the ERK pathway and antagonized by stress-activated p38 MAPK cascade (84) . During liver development, cyclin D 1 content is inversely related to p38 MAPK activity, which in turn may be regulated by ROS (81) and NO (104) . NO may modulate per se the expression of cell cycle regulatory proteins (138) ; NO induces cytostasis by inhibition of cyclin D 1 or by inhibition of cdc2 (cyclin E and A pathways) (104) . In accord, NO has antimitogenic effects on cultured hepatocytes (51) .
During rat liver development, we observed that modulation of mtNOS and subsequent redox changes regulate MAPK cascades and cell cycle regulatory proteins in the sequence of proliferating to quiescent cell stages (Fig. 2) In this context, the synchronized increases of mitochondrial activities, mtNOS, and [H 2 O 2 ] ss operate on the balance of signaling pathways to drive the transition from proliferation to quiescence in rat liver development. In the same way, we recently reported that a critical reduction of mtNOS activity and [H 2 O 2 ] ss contribute to tumor-persistent ("embryonic") behavior (58) .
On the other side, an increase of mtNOS and H 2 O 2 follows rat brain and cerebellum development, at the phase of synaptic plasticity (119). High mitochondrial NO and H 2 O 2 yields are detectable over the last days of pregnancy and persist for ϳ10 -12 days after delivery and for up to 20 days in cerebellum, with prolonged plasticity. This mitochondrial response is consistent with the arrest of neuroblast proliferation and with apoptosis, the two components of structural synaptic plasticity. Neurite growth and connection are the bases for the integration and differentiation of the neural anatomical network; however, apoptosis of nonconnected neurons is essential for this purpose.
NO, H2O2, AND CELL APOPTOSIS
In the past decades, one of the more fascinating events was the discovery of programmed cell death or apoptosis. The discovery of diverse apoptosis pathways involving signals primarily via the death receptors (extrinsic pathway) or the mitochondria (intrinsic pathway) using caspases as effector molecules has dominated the field. Caspases are cysteine proteases that cleave specific aspartate residues in other regulatory proteins like Bcl-2, Bax, and MEKK (for review, see Ref. 83) . In the extrinsic pathway, binding of membrane ligands like TNF-␣ and Fas to membrane receptors triggers the activation of caspases and the induction of apoptosis (6, 106) . In the intrinsic program, mitochondrial damage results in the release of cytochrome c, triggering the assembly of the apoptosome complex with apoptotic protease-activating factor-1 as central scaffold protein that directly recruits caspase 9, which in turn elicits caspase 3 effects (31).
It is noteworthy that mitochondria are clearly involved in the process of programmed cell death. Different agents that promote apoptosis are associated with mitochondrial changes. For instance, proapoptotic p53 protein induces gene transcription of redox-related genes encoding proteins that lead to oxidative stress (66) . In addition, the increase of intracellular Ca 2ϩ levels consecutive to cell injury or dysfunction may open the mitochondrial pore transition and drastically inhibit oxidative phosphorylation (107) . The effects of oxidants may rely on the potential changes in thiol groups of caspases.
Oxygen active species and NO are now recognized as important regulators of apoptotic pathways (55, 66, 121) . Proapoptotic activities of NO have been demonstrated in different cells and tissues (1, 46) . NO can directly induce cytochrome c release through mitochondrial membrane potential loss (46) or by tyrosine nitration of cytochrome c (67) . NO donors or endogenous NO induces apoptotic cell death with the activation of JNK/SAPK and p38 MAPK and caspase 3 or inactivation of NF-B. In this way, increased inducible NOS expression and NO production act as a negative regulatory feedback modulator of NF-B activity (102) .
The stimulation or inhibition of NF-B may be related to proliferative or apoptotic effects. NF-B is activated by several agents, including cytokines, oxidant free radicals, inhaled particles, ultraviolet irradiation, and bacterial or viral products (42) . Inappropriate activation of NF-B has been linked to inflammatory events associated with autoimmune arthritis, asthma, septic shock, lung fibrosis, glomerulonephritis, atherosclerosis, and acquired immunodeficiency syndrome. In contrast, complete and persistent inhibition of NF-B has been linked directly to apoptosis, inappropriate immune cell development, and delayed cell growth. Disruption of the NF-B gene is associated with embryo lethality; many antiapoptotic pathways like Bcl-2 are induced by NF-B. Accordingly, new therapeutic strategies have been developed in cancer treatment, including inhibition of the NF-B pathway (144) .
Many proapoptotic effects of NO may be mediated by peroxynitrite as a by-product of NO and mitochondrial-derived O 2 Ϫ (15, 108) (Fig. 3) . Cytotoxic effects of NO and peroxynitrite on tumor cells have been shown to be the result of DNA damage, which induces the accumulation of p53. NO-mediated p53 accumulation induces cell cycle arrest by p21 upregulation or apoptosis by increase in Bax/Bcl-xL, cytochrome c release, and caspase activation (100). Moreover, induction of apoptosis may require the fine biochemical interplay between oxygen and nitrogen species (99) ; the mechanism could be important in the step control and elimination of transformed cells (11) .
On the other hand, NO has antiapoptotic effects that can be associated with cGMP production, which suppresses mitochondrial cytochrome c release, ceramide generation, and caspase activation (46, 77) . Other antiapoptotic NO pathways include S-nitrosylation and inactivation of caspases thiols and upregulation of antiapoptotic genes like that of heme oxygenase (127) and Hsp70, which protects hepatocytes from apoptosis induced by oxidative and nitrative stress (46) . 
THE LACK OF CELL AND MITOCHONDRIAL NO: A NEW GATEWAY TO PATHOLOGY
Deficient S-nitrosylation has also been linked to disease pathogenesis (128) . Specifically, increased activity of the denitrosylase S-nitrosoglutathione reductase in asthmatic lungs depletes levels of the endogenous bronchodilator S-nitrosoglutathione, leading to airway hyperresponsiveness (115) . Likewise, in sickle cell anemia, the sickle cell hemoglobin is deficient in the intramolecular and intermolecular transfer of NO moieties. Consequently, red blood cell membrane S-nitrosothiol levels are decreased and hypoxic vasodilation is impaired, leading to vasoocclusion in hypoxic tissue (101) .
Recently, it was reported that deficient protein S-nitrosylation contributes to the development of amyotrophic lateral sclerosis (ALS); ALS is one of the most common adult-onset neurodegenerative diseases and is characterized by degeneration of motoneurons in the spinal cord, brain stem, and cortex (26) , and 10 -20% of cases are due to mutations in the SOD1 gene (122, 123) . Considering that SOD1 mutations lead to an increase of the denitrosylase activity of the enzyme, the authors found that deficient S-nitrosylation can disrupt the functions of proteins that are regulated by this mechanism (like GAPDH) and that increased denitrosylase activity is a toxic gain of function of SOD1 mutants.
In the same way but close to the mitochondrial field, we previously reported the existence of defective NOS and mt-NOS in mitochondria from tumor cells (58) . Low NO levels were associated with low H 2 O 2 yields, high proliferation rate, and activation of ERK1/2, a pattern resembling that shown in embryonic development (32, 44) . Because proapoptotic p38 or JNK1/2 did not become phosphorylated, we surmise the results are part of the "reciprocal dance between cancer and fetal development." In addition, different cell lines normally underwent proliferation arrest when supplemented with 10 M H 2 O 2 (52).
CONCLUDING REMARKS
Many years ago, we proposed that, depending on matrix concentration, NO is utilized in mitochondria with formation of H 2 O 2 or peroxynitrite (108) . Altogether, these species induce profound changes in normal or pathological cell processes. A moderately low level of these mitochondrial activities is compatible with proliferation and mitochondrial biogenesis (95, 98) ; accordingly, stem proliferating cells have a low number of mitochondria, with resultant low [H 2 O 2 ] ss . Also, embryonic and tumor cells share a distinctive pattern characterized by low mitochondrial and cell NO and H 2 O 2 yields. A controlled decrease of mitochondrial respiration accompanies proliferation and tumor behavior (132) . Likewise and depending on state 3-to-state 4 O 2 uptake ratios and ATP and nucleotide demands, control of cell proliferation by mitochondrial respiration acts by setting [H 2 O 2 ] ss with differential activation of MAPKs, Akt, and cyclin D. In this sense, very low NO inhibits COX and determines low H 2 O 2 yield. Otherwise, selective and persistent high NO yields block complexes I, II, and III and further increase active species production in those sites and associates with cell arrest and/or with activation of the proapoptotic pathways. Interestingly, selective nitration of complex I components (57) could determine the final phenotype in some conditions, like hypothyroidism. On the other hand, lack of mitochondrial NO drives mitochondria and cells to deregulate modulation of metabolism by S-nitrosylation or to restrain H 2 O 2 increase, leading to the onset of diseases with high mortality rate, like ALS or cancer.
